NASDAQ
According to Zyberno, COGNEX CORP (CGNX) is not a buy — GOOD BUSINESS (67/100) with a negative Margin of Safety of -100.0% and a Brina Gap of -27.6% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, COGNEX CORP (CGNX) trades at $60.46 against an estimated intrinsic value per share of $29.41 — a -100.0% Margin of Safety based on Owner Earnings of $241.37M TTM, projected at 10.9% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -27.6% weakens the case: based on the company's ROIC (13.9%) and reinvestment rate (-54.6%), the business can fundamentally grow at -7.6% — but the current enterprise value implies the market expects 20.0%. This places CGNX in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -4.0% annually.
Over the trailing twelve months, CGNX generated $241.37M in Owner Earnings. Capital was deployed as follows: $99.00M returned via share buybacks, $55.27M paid as dividends, $9.00M invested in capital expenditures. Reinvestment rate: -54.6%. Owner Earnings have grown at 10.9% annually over the trailing five years using log-linear regression.